These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26718977)

  • 41. Association of BAFF with PI3K/Akt/mTOR signaling in lupus nephritis.
    Ge F; Wang F; Yan X; Li Z; Wang X
    Mol Med Rep; 2017 Nov; 16(5):5793-5798. PubMed ID: 28849060
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TERT Promoter Mutation c.-124C>T Commonly Occurs in Low-Grade Fibromatosis-like Metaplastic Breast Carcinoma.
    Webersinke G; Burghofer J; Malli T; Rammer M; Jahn SW; Niendorf A; Tavassoli FA; Moinfar F
    Arch Pathol Lab Med; 2023 Dec; 147(12):1451-1457. PubMed ID: 36897999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions.
    Troxell ML; Brunner AL; Neff T; Warrick A; Beadling C; Montgomery K; Zhu S; Corless CL; West RB
    Mod Pathol; 2012 Jul; 25(7):930-7. PubMed ID: 22460814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenoma.
    Pfarr N; Sinn HP; Klauschen F; Flechtenmacher C; Bockmayr M; Ridinger K; von Winterfeld M; Warth A; Lorenz K; Budczies J; Penzel R; Lennerz JK; Endris V; Weichert W; Stenzinger A
    Genes Chromosomes Cancer; 2016 Feb; 55(2):113-9. PubMed ID: 26493284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Worldwide prevalence of PI3K-AKT-mTOR pathway mutations in head and neck cancer: A systematic review and meta-analysis.
    Moura AC; Assad DX; Amorim Dos Santos J; Porto de Toledo I; Barra GB; Castilho RM; Squarize CH; Guerra ENS
    Crit Rev Oncol Hematol; 2021 Apr; 160():103284. PubMed ID: 33675910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway.
    Hori Y; Hirose K; Aramaki-Hattori N; Suzuki S; Nakayama R; Inoue M; Matsui T; Kohara M; Toyosawa S; Morii E
    Diagn Pathol; 2020 Jul; 15(1):98. PubMed ID: 32711543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional analysis of non-hotspot AKT1 mutants found in human breast cancers identifies novel driver mutations: implications for personalized medicine.
    Yi KH; Axtmayer J; Gustin JP; Rajpurohit A; Lauring J
    Oncotarget; 2013 Jan; 4(1):29-34. PubMed ID: 23237847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Germline activating MTOR mutation arising through gonadal mosaicism in two brothers with megalencephaly and neurodevelopmental abnormalities.
    Mroske C; Rasmussen K; Shinde DN; Huether R; Powis Z; Lu HM; Baxter RM; McPherson E; Tang S
    BMC Med Genet; 2015 Nov; 16():102. PubMed ID: 26542245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MAP kinase and mammalian target of rapamycin are main pathways of gallbladder carcinogenesis: results from bioinformatic analysis of next generation sequencing data from a hospital-based cohort (NCT05404347).
    Rajput M; Chigurupati S; Purwar R; Shukla M; Pandey M
    Mol Biol Rep; 2022 Nov; 49(11):10153-10163. PubMed ID: 36018415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Next-generation sequencing of uveal melanoma with clinical and histological correlations: Prognostic value of new mutations in the PI3K/AKT/mTOR pathway.
    Pérez-Pérez M; Agostino A; de Sola-Llamas CG; Ruvolo M; Vilches-Arenas A; Relimpio-López MI; Espejo-Arjona F; Macías-García L; De Miguel-Rodríguez M; García-Escudero A; Idoate MA; Ríos-Martín JJ
    Clin Exp Ophthalmol; 2023 Nov; 51(8):822-834. PubMed ID: 37803816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Somatic activating mutations in
    Rodriguez-Laguna L; Agra N; Ibañez K; Oliva-Molina G; Gordo G; Khurana N; Hominick D; Beato M; Colmenero I; Herranz G; Torres Canizalez JM; Rodríguez Pena R; Vallespín E; Martín-Arenas R; Del Pozo Á; Villaverde C; Bustamante A; Ayuso C; Lapunzina P; Lopez-Gutierrez JC; Dellinger MT; Martinez-Glez V
    J Exp Med; 2019 Feb; 216(2):407-418. PubMed ID: 30591517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.
    D'Gama AM; Geng Y; Couto JA; Martin B; Boyle EA; LaCoursiere CM; Hossain A; Hatem NE; Barry BJ; Kwiatkowski DJ; Vinters HV; Barkovich AJ; Shendure J; Mathern GW; Walsh CA; Poduri A
    Ann Neurol; 2015 Apr; 77(4):720-5. PubMed ID: 25599672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. E17K substitution in AKT1 in prostate cancer.
    Boormans JL; Korsten H; Ziel-van der Made AC; van Leenders GJ; Verhagen PC; Trapman J
    Br J Cancer; 2010 May; 102(10):1491-4. PubMed ID: 20407443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular Genetics of the PI3K-AKT-mTOR Pathway in Genodermatoses: Diagnostic Implications and Treatment Opportunities.
    Vahidnezhad H; Youssefian L; Uitto J
    J Invest Dermatol; 2016 Jan; 136(1):15-23. PubMed ID: 26763419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular Genetic Landscape of Sclerosing Pneumocytomas.
    Boland JM; Lee HE; Barr Fritcher EG; Voss JS; Jessen E; Davila JI; Kipp BR; Graham RP; Maleszewski JJ; Yi ES
    Am J Clin Pathol; 2021 Feb; 155(3):397-404. PubMed ID: 33145590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activating mutations of TOR (target of rapamycin).
    Hardt M; Chantaravisoot N; Tamanoi F
    Genes Cells; 2011 Feb; 16(2):141-51. PubMed ID: 21210909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic Causes of Vascular Malformations and Common Signaling Pathways Involved in Their Formation.
    Rose AL; Cathey SS
    Dermatol Clin; 2022 Oct; 40(4):449-459. PubMed ID: 36243432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Germline mutations in PIK3CA and AKT1 in Cowden syndrome and related diseases].
    Dereure O
    Ann Dermatol Venereol; 2013 Nov; 140(11):739-40. PubMed ID: 24206815
    [No Abstract]   [Full Text] [Related]  

  • 59. Novel neonatal presentation of megalencephaly-polymicrogyria-pigmentary mosaicism syndrome (MPPM) related to MTOR mutation: Report of a case.
    Taylor DL; Wildin RS; Morley KW
    Pediatr Dermatol; 2021 Mar; 38(2):536-537. PubMed ID: 33325571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Next generation sequencing of the nidus of early (adenosquamous proliferation rich) radial sclerosing lesions of the breast reveals evidence for a neoplastic precursor lesion.
    Wilsher MJ; Owens TW; Allcock RJ
    J Pathol Clin Res; 2017 Apr; 3(2):115-122. PubMed ID: 28451460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.